NoQuestionsAI

NOQIntelligence™

Regulatory intelligence for the GRAS dossier lifecycle.

NOQIntelligence™ is the active data and analysis layer behind NoQuestionsAI. It is built to help teams compare a developing GRAS dossier against FDA-facing precedent, known review patterns, and the kinds of evidentiary issues that can slow or compromise a no-questions outcome.

Patent Pending
NOQIntelligence™GRAS process database
No-questions letters
Question patterns
Dossier sections
Risk signals
Regulatory data architecture

An active database organized around how GRAS review actually works.

GRAS dossier quality depends on more than assembling citations. It depends on whether the scientific basis is coherent, whether each section is supported by the correct evidence, and whether the submission anticipates the questions a reviewer may ask. NOQIntelligence™ is built around that operational reality.

GRAS notice corpus

Structured precedent from FDA-facing GRAS workflows

NOQIntelligence™ is designed around the practical record of the GRAS process: public no-questions letters, notice summaries, ingredient identities, use conditions, scientific rationales, and reviewer-facing issues that recur across submissions.

Question patterning

Signals derived from likely review friction

NOQIntelligence™ maps dossier content against patterns associated with clarification requests, evidentiary gaps, exposure questions, specification ambiguity, manufacturing uncertainty, and unsupported safety conclusions.

Dossier context

Comparison against the actual submission record

Rather than treating each answer as isolated text, NOQIntelligence™ evaluates the developing dossier as an integrated regulatory document with dependencies across identity, manufacturing, specifications, exposure, safety, and history.

Applied workflow

From source material to regulatory readiness signal.

NOQIntelligence™ supports a disciplined review loop: retrieve relevant precedent, assess section-level support, identify potential review friction, and translate those signals into actionable dossier improvements.

  1. Ingredient identity and technical effect are normalized against comparable GRAS notice patterns.
  2. Manufacturing, specifications, intended use, exposure, and safety narrative are evaluated for internal consistency.
  3. Relevant NOQIntelligence™ matches are surfaced where precedent or risk signals can inform the dossier strategy.
  4. The Risk Assessor uses this context to characterize potential pushback before the dossier is treated as submission-ready.

Built for teams that need regulatory judgment, not generic content.

NOQIntelligence™ strengthens NoQuestionsAI for GRAS work by evaluating dossier development through the lens of precedent, evidentiary sufficiency, and likely FDA-facing questions. NoQuestionsAI uses that intelligence to support better regulatory decisions before submission pressure begins.

View Plans